Our governance: senior leadership, boards and groups
Updated on
Our governance promotes transparency, scientific rigor, and stakeholder engagement. The Institute's various bodies bring together expertise from the cancer control community to guide our strategy and uphold our core values.
Senior Leadership
Norbert IFRAH, MD, PhD, was appointed President on June 2016. He was previously head of the Haematology Department at Angers University Hospital.
Nicolas SCOTTÉ was appointed Managing Director in 2024. He was previously Social Protection and Social Accounts Adviser to the French President.
Learn more: our chart (in French)
Board of Administrators
Our Board of Administrators includes representatives of all the stakeholders involved in cancer control: representatives of the core Public Interest Group (GIP) members and eight qualified individuals, a total of 28 directors. State representatives hold the majority (53 per cent) of the votes. The Board decides in particular on the Institute's overall strategy.[IO1] [CA2]
Scientific Board
The International Scientific Advisory Board is composed of world-renowned cancer experts appointed by the Ministries for Health and Research. It gives advice and recommendations, and ensures the consistency of the medical and scientific strategy. Its members meet up to twice a year. The INCa's president, the managing director and the head of the Scientific Board are appointed by decree for five-year terms.
General Assembly
Our General Assembly gathers 11 representatives of the Public Interest Group (GIP), 7 of whom are appointed by the French government.
The General Assembly deliberates over such things as amendments to the Institute's constitutional convention and the acceptance or the exclusion of a member.
Ethics Committee
The Ethics Committee is a permanent consultative body whose members are appointed by the Board of Directors. It comprises seven people, including one representative of the Health Democracy Committee (see below). It aims to advise the Board of Directors on all deontology- and ethics-related topics.
Ethics officer
The ethics officer is responsible for ensuring compliance with the obligations to declare and prevent conflicts of interest among executives, management, the collegial bodies of the National Cancer Institute, and experts engaged by the INCa. This role has been assigned to an external individual to maintain its independence.
Health Democracy Committee
The Health Democracy Committee is a permanent consultative body positioned close to the presidency and reporting to the Board of Directors. It aims at fostering the health democracy process through direct dialogue between stakeholders. This committee has regular workshop meetings at the Institute.
Its current president is Philippe Gazagnes.